HF
INFI

HRT Financial’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

HRT Financial’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,340
Closed -$6K – 3447
2022
Q4 		$6K Buy
+11,340
New +$9.65K ﹤0.01% 2265
2022
Q3 		– Sell
-19,995
Closed -$12K – 3734
2022
Q2 		$12K Buy
+19,995
New +$15.3K ﹤0.01% 2663
2021
Q2 		– Sell
-151,043
Closed -$487K – 3726
2021
Q1 		$487K Buy
+151,043
New +$504K ﹤0.01% 1813
2015
Q3 		– Sell
-11,675
Closed -$127K – 204
2015
Q2 		$127K Buy
+11,675
New +$150K 0.06% 148

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's INFI Position: Q1 2023 in Review

HRT Financial sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2023, closing a stake of 11,340 shares — an estimated $6K sold.

HRT Financial first reported a position in INFI in Q2 2015 and held it in 4 quarters. The position peaked at $487K in Q1 2021. 53 funds tracked by Wall St. Rank hold INFI as of Q1 2023.

  • HRT Financial reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 11,340 Infinity Pharmaceuticals, Inc. shares in Q1 2023, an estimated $6K.
  • HRT Financial first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2015 and held it in 4 quarters.
  • HRT Financial's Infinity Pharmaceuticals, Inc. position peaked at $487K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.